Geisinger will expand its precision medicine project beyond research to preventive care, the Danville, PA-based integrated health system announced Sunday. The project already reports clinically actionable genomic results to research participants and their primary care physicians, and plans to launch a clinical DNA pilot program with 1,000 patients in the next six months. “Understanding the genome warning signals of every patient will be an essential part of wellness planning and health management,” Geisinger President and CEO David Feinberg, M.D., told participants at the HLTH Conference in Las Vegas. “Geisinger patients will be able to work with their family physician to modify their lifestyle and minimize risks that may be revealed.”

Related News Articles

Headline
The Department of the Treasury and Internal Revenue Service today expanded the list of preventive care benefits that high-deductible health plans can cover…
Headline
Under a new Centers for Medicare…
Insights and Analysis
Genesis Health System in Davenport, Iowa, estimates its employee wellness program has saved $53 million in health care costs over a decade by incentivizing…
Insights and Analysis
Also in this weekly roundup of health care news: Study says preschoolers are at ‘golden age’ for forming lifelong healthy habits, and the extraordinary effect…
Headline
U.S. News and World Report will host a Twitter chat on building healthy communities at 1:30 p.m. ET Oct. 10.
Insights and Analysis
St. John’s Hospitals in Oxnard, Calif., are ensuring local women get needed preventive cancer care regardless of their income status; Connecticut Children’s…